NCT06193499

Brief Summary

This is a randomized double-blinded randomized comparison between injection of platelet rich plasma (PRP) and placebo for thumb basale osteoarthritis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2024Jun 2027

First Submitted

Initial submission to the registry

December 20, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

January 17, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

June 3, 2025

Status Verified

June 1, 2025

Enrollment Period

3 years

First QC Date

December 20, 2023

Last Update Submit

June 1, 2025

Conditions

Keywords

CMC-1 jointthumb basal jointPRPPlatelet-rich plasma

Outcome Measures

Primary Outcomes (1)

  • Pain on load in thumb

    Pain on load (numerical rating scale (NRS) 0-100, higher score represents more pain)

    6 months after the first injection.

Secondary Outcomes (15)

  • Patient-rated Wrist and Hand (PRWHE) score

    3 months

  • Patient-rated Wrist and Hand (PRWHE) score

    6 months

  • Patient-rated Wrist and Hand (PRWHE) score

    12 months

  • Nelson thumb score

    3 months

  • Nelson thumb score

    6 months

  • +10 more secondary outcomes

Study Arms (2)

Platelet rich plasma (PRP)

ACTIVE COMPARATOR

High-concentration PRP injection PRP injection (0,6-1ml). Arthrex ACPmax system.

Procedure: Platelet rich plasma (PRP)

Placebo

PLACEBO COMPARATOR

intraarticular saline injection (0,6-1ml)

Other: Placebo

Interventions

Intra-articular injection of platelet rich plasma (PRP)

Platelet rich plasma (PRP)
PlaceboOTHER

Intra-articular Saline injection (0,6-1ml)

Placebo

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Osteoarthritis in the thumb base
  • Radiological Eaton Littler class 1-3.
  • Clinical signs of thumb base osteoarthritis )pain at palpation of the CMC-1 joint and pain during provocation/grinding test).

You may not qualify if:

  • Rheumatoid arthritis
  • Ongoing infection in the hand or wrist
  • History of gout or pseudogout in the hand
  • Inability to co-operate with the follow-up protocol (language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction).
  • Chronic pain syndrome / centralized pain.
  • Intra-articular injection in the affected joint within 6 months.
  • Eaton Littler class 4 (symptomatic STT joint osteoarthritis).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Hand Surgery Södersjukhuset

Stockholm, S-11883, Sweden

RECRUITING

Related Publications (1)

  • von Kieseritzky J, Wilcke M. High-concentrated platelet-rich plasma (PRP) versus placebo in osteoarthritis in the thumb base: study protocol for an assessor-blinded randomized controlled trial. Trials. 2024 Nov 26;25(1):797. doi: 10.1186/s13063-024-08636-2.

Central Study Contacts

Johanna VonKieseritzky, MD. PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
blind fold on participants. No infomration about given treatment to outcome assessors.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate profesoor

Study Record Dates

First Submitted

December 20, 2023

First Posted

January 5, 2024

Study Start

January 17, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 30, 2027

Last Updated

June 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations